Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?

To: NTTG who wrote (11673)	11/17/2012 2:39:46 PM
From: Mimbari	3 Recommendations Read Replies (1) \| Respond to of 13111

Clearly the FDA is not impressed? Do you work for the FDA or are you in contact with them?? They have lost the ability to include Stage IV? Nowhere is this information published that they lost the ability. Who the heck would want stage IV patients in their study anyway? Are not those the patients at deaths door? Now having first hand knowledge in the drug development process is admitting being directly involved in developing drugs, is this not so? Now I will agree that the SP is low and everybody is not happy about that. I will also agree with you that the failed IPO is a great disappointment. As regard to your opinions, please start your posts with the notice that the following is in your opinion. Lets keep facts separate from opinions. Threatened by MGT? What in the sam doodle is that comment?